Developing a Product Launch Strategy for an Orphan Drug
Published: | Updated:
Commercializing an orphan drug can be challenging, however, using a framework and a checklist that incorporates the right elements can prove beneficial.
Amanjeet Saluja
Advertisement
Principal, Axtria
Articles by Amanjeet Saluja
Advertisement
Latest Updated Articles
Developing a Product Launch Strategy for an Orphan DrugPublished: September 14th 2021 | Updated: September 15th 2021
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5